Style | Citing Format |
---|---|
MLA | Ataei Z, et al.. "Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation." PLoS ONE, vol. 18, no. 2 February, 2023, pp. -. |
APA | Ataei Z, Nouri Z, Tavakoli F, Pourreza MR, Narrei S, Tabatabaiefar MA (2023). Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation. PLoS ONE, 18(2 February), -. |
Chicago | Ataei Z, Nouri Z, Tavakoli F, Pourreza MR, Narrei S, Tabatabaiefar MA. "Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation." PLoS ONE 18, no. 2 February (2023): -. |
Harvard | Ataei Z et al. (2023) 'Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation', PLoS ONE, 18(2 February), pp. -. |
Vancouver | Ataei Z, Nouri Z, Tavakoli F, Pourreza MR, Narrei S, Tabatabaiefar MA. Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation. PLoS ONE. 2023;18(2 February):-. |
BibTex | @article{ author = {Ataei Z and Nouri Z and Tavakoli F and Pourreza MR and Narrei S and Tabatabaiefar MA}, title = {Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation}, journal = {PLoS ONE}, volume = {18}, number = {2 February}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Ataei Z AU - Nouri Z AU - Tavakoli F AU - Pourreza MR AU - Narrei S AU - Tabatabaiefar MA TI - Novel In-Frame Duplication Variant Characterization in Late Infantile Metachromatic Leukodystrophy Using Whole-Exome Sequencing and Molecular Dynamics Simulation JO - PLoS ONE VL - 18 IS - 2 February SP - EP - PY - 2023 ER - |